Michels, S. Y. F., Scheel, A. H., Wündisch, T., Heuckmann, J. M., Menon, R., Puesken, M., . . . Wolf, J. (2017). ALK(G1269A) mutation as a potential mechanism of acquired resistance to crizotinib in an ALK-rearranged inflammatory myofibroblastic tumor. NPJ Precis Oncol.
Παραπομπή Chicago StyleMichels, Sebastian Y. F., et al. "ALK(G1269A) Mutation As a Potential Mechanism of Acquired Resistance to Crizotinib in an ALK-rearranged Inflammatory Myofibroblastic Tumor." NPJ Precis Oncol 2017.
Παραπομπή MLAMichels, Sebastian Y. F., et al. "ALK(G1269A) Mutation As a Potential Mechanism of Acquired Resistance to Crizotinib in an ALK-rearranged Inflammatory Myofibroblastic Tumor." NPJ Precis Oncol 2017.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.